Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

kaiser foundation hospitals - amiloride hydrochloride (unii: fzj37245uc) (amiloride - unii:7dzo8eb0z3) - amiloride hydrochloride anhydrous 5 mg

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

avera mckennan hospital - amiloride hydrochloride (unii: fzj37245uc) (amiloride - unii:7dzo8eb0z3) - amiloride hydrochloride anhydrous 5 mg

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - quinapril hydrochloride -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate - indications as at 15 july 1998 : kaluril's main indication is as concomitant therapy with diuretics to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy with thiazides or other more potent diuretics. kaluril when used alone, has mild diuretic and antihypertensive activity. oedema of cardiac origin. although kaluril alone may provide adequate diuresis for some patients with oedema of cardiac origin, it is primarily indicated for concomitant use in patients receiving thiazides or more potent saluretic diuretic agents. in these patients it may provide increased sodium, chloride and water excretion and decreased potassium excretion. the positive effect of kaluril on potassium balance may be especially important for digitalised cardiac patients, in whom potassium depletion sensitises or exaggerates the response of the heart to the toxic effects of digitalis (e.g. increased ventricular irritability), which may precipitate digitalis intoxication with potentially seriou

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - amiloride hydrochloride; cyclopenthiazide - oral tablet - 2.5mg ; 250microgram

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - amiloride hydrochloride - oral tablet - 5mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - amiloride hydrochloride; furosemide - oral tablet - 2.5mg ; 20mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - amiloride hydrochloride; furosemide - oral tablet - 2.5mg ; 20mg

Ηνωμένο Βασίλειο - Αγγλικά - MHRA (Medicines & Healthcare Products Regulatory Agency)

wockhardt uk ltd - amiloride hydrochloride; hydrochlorothiazide - oral tablet - 2.5mg ; 25mg

Αρμενία - Αγγλικά - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

remedica ltd - amiloride (amiloride hydrochloride), hydrochlorothiazide - tablets - 5mg+50mg